Other than AD and PD, GSK-3β has emerged as an interesting therapeutic target in pathological mechanisms, including inflammatory diseases, cancers, cardiovascular diseases, diabetes, and bone disorders [8]. The gene discussed is GSK3B; the disease is bone disorder.